GlassScriptPhysician profile
Kayla M Bond
NPI 1790191104
$1,370.34
in general payments reported to CMS, 2019-2025
23 companies · $231 in 2025
The $231 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $257 · 2020: $80.54 · 2021: $38.31 · 2022: $262 · 2023: $113 · 2024: $388 · 2025: $231.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $732.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $732.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $220.34 | 2022-2025 | Acthar |
| Sun Pharmaceutical Industries INC. | $153.34 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $144.65 | 2019-2023 | |
| Harrow Eye, LLC | $124.45 | 2024-2025 | Vevye |
| Tarsus Pharmaceuticals, INC. | $93.87 | 2024-2025 | Xdemvy |
| Bausch & Lomb Americas INC. | $73.89 | 2022-2025 | Infuse, Xiidra, Miebo |
| Oyster Point Pharma, INC. | $69.82 | 2022-2024 | Tyrvaya |
| Kala Pharmaceuticals, INC. | $55.93 | 2019 | |
| Johnson & Johnson Vision Care, INC. | $49.39 | 2022-2023 | Acuvue |
| Biotissue Holdings INC. | $48.46 | 2019-2021 | |
| Coopervision INC. | $48.46 | 2024-2025 | Myday Contact Lens |
| Dompe US, INC. | $48.09 | 2020-2024 | Oxervate |
| Alcon Vision LLC | $35.42 | 2024-2025 | Precision7, Total30 |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $28.30 | 2019 | |
| Eyevance Pharmaceuticals LLC | $23.50 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $21.82 | 2022 | |
| Quidel Corporation | $21.37 | 2022 | |
| Abb Con-Cise Optical Group LLC | $20.72 | 2023 | Contact Lens, Spectacle Lenses |
| Aerie Pharmaceuticals, INC. | $19.43 | 2019 | |
| Thea Pharma INC. | $18.97 | 2024 | Iyuzeh |
| Horizon Therapeutics Plc | $18.11 | 2022 | |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 | |
| Shire North American Group INC | $14.77 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kayla Bond listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.